Protease inhibitor-resistant HIV-1 from patients with preserved CD4 cell counts is cytopathic in activated CD4 T

T J Liegler1, M S Hayden, K H Lee

  • 1Gladstone Institute of Virology and Immunology, San Francisco, California 94141-9100, USA.

AIDS (London, England)
|February 24, 2001
PubMed
Abstract

Insights

Protease inhibitor-resistant HIV isolates from patients with stable CD4 counts are as cytopathic as sensitive strains. Virus cytopathicity is mainly determined by coreceptor preference, not drug resistance.

Area of Science:

  • Virology
  • Immunology
  • HIV Research

Background:

  • Long-term virologic failure in HIV patients on protease inhibitor (PI) therapy can lead to PI-resistant viral strains.
  • Some patients maintain stable or increasing CD4 T-cell counts despite virologic failure, suggesting compensatory mechanisms.
  • The cytopathicity of PI-resistant HIV isolates and its impact on CD4 T-cell counts require further investigation.

Purpose of the Study:

  • To evaluate the CD4 T-cell cytopathicity of protease inhibitor (PI)-resistant HIV isolates from patients with preserved CD4 cell counts after long-term virologic failure.
  • To compare the cytopathicity of PI-resistant isolates with PI-sensitive isolates.
  • To determine factors influencing the cytopathicity of PI-resistant HIV.

Main Methods:

  • Primary HIV-1 isolates from 14 patients with virologic failure on PI therapy were analyzed.
  • Replication and cytopathicity were assessed in peripheral blood mononuclear cell cultures.
  • Coreceptor use, syncytia-inducing (SI) phenotype, and protease sequences were determined.

Main Results:

  • PI-resistant isolates from patients on therapy showed decreased PI susceptibility.
  • PI-resistant syncytia-inducing (SI) isolates were highly to moderately cytopathic; non-SI isolates were less cytopathic.
  • The cytopathicity of PI-resistant isolates was similar to PI-sensitive isolates and not altered by PI presence.

Conclusions:

  • Primary PI-resistant HIV isolates from patients with virologic rebound but stable CD4 counts are as cytopathic as PI-sensitive isolates.
  • Coreceptor preference, not PI resistance, primarily determines HIV cytopathicity.
  • Sustained immune responses after PI regimen failure are not due to less cytopathic PI-resistant strains.

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...